Clinical outcomes and predictors of success with Impella weaning in cardiogenic shock: a single-center experience

被引:7
|
作者
Matassini, M. V. [1 ]
Marini, M. [1 ]
Angelozzi, A. [2 ]
Angelini, L. [1 ]
Shkoza, M. [1 ]
Compagnucci, P. [3 ,4 ,5 ]
Falanga, U. [3 ,4 ,5 ]
Battistoni, I. [1 ]
Pongetti, G. [1 ]
Francioni, M. [1 ]
Piva, T. [6 ]
Mucaj, A. [6 ]
Nicolini, E. [6 ]
Maolo, A. [6 ]
Di Eusanio, M. [7 ]
Munch, C. [8 ]
Dello Russo, A. [3 ,4 ,5 ]
Perna, G. [1 ]
机构
[1] Osped Riuniti Ancona, Cardiovasc Dept, Cardiol Div, Cardiac Intens Care Unit, Ancona, Italy
[2] G Mazzini Hosp, Cardiovasc Dept, Unit Cardiol & Cardiac Intens Therapy, Teramo, Italy
[3] Univ Hosp Osped Riuniti Ancona, Dept Biomed Sci & Publ Hlth, Ancona, Italy
[4] Univ Hosp Osped Riuniti Ancona, Cardiol & Arrhythmol Clin, Ancona, Italy
[5] Marche Polytech Univ, Ancona, Italy
[6] Osped Riuniti Ancona, Cardiovasc Dept, Intervent Cardiol Cardiol Div, Ancona, Italy
[7] Osped Riuniti Ancona, Cardiovasc Dept, Cardiac Surg Unit, Ancona, Italy
[8] Osped Riuniti Ancona, Anaesthesia & Cardiac Surg Intens Care, Ancona, Italy
来源
关键词
heart failure; Impella; weaning; outcomes; complications; cardiogenic shock; MECHANICAL CIRCULATORY SUPPORT; VENTRICULAR SUPPORT; DEVICE; PUMP;
D O I
10.3389/fcvm.2023.1171956
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IntroductionCardiogenic shock (CS) is a severe syndrome with poor prognosis. Short-term mechanical circulatory support with Impella devices has emerged as an increasingly therapeutic option, unloading the failing left ventricle (LV) and improving hemodynamic status of affected patients. Impella devices should be used for the shortest time necessary to allow LV recovery because of time-dependent device-related adverse events. The weaning from Impella, however, is mostly performed in the absence of established guidelines, mainly based on the experience of the individual centres. MethodsThe aim of this single center study was to retrospectively evaluate whether a multiparametrical assessment before and during Impella weaning could predict successful weaning. The primary study outcome was death occurring during Impella weaning and secondary endpoints included assessment of in-hospital outcomes. ResultsOf a total of 45 patients (median age, 60 [51-66] years, 73% male) treated with an Impella device, 37 patients underwent impella weaning/removal and 9 patients (20%) died after the weaning. Non-survivors patients after impella weaning more commonly had a previous history of known heart failure (p = 0.054) and an implanted ICD-CRT (p = 0.01), and were more frequently treated with continuous renal replacement therapy (p = 0.02). In univariable logistic regression analysis, lactates variation (%) during the first 12-24 h of weaning, lactate value after 24 h of weaning, left ventricular ejection fraction (LVEF) at the beginning of weaning, and inotropic score after 24 h from weaning beginning were associated with death. Stepwise multivariable logistic regression identified LVEF at the beginning of weaning and lactates variation (%) in the first 12-24 h from weaning beginning as the most accurate predictors of death after weaning. The ROC analysis indicated 80% accuracy (95% confidence interval = 64%-96%) using the two variables in combination to predict death after weaning from Impella. ConclusionsThis single-center experience on Impella weaning in CS showed that two easily accessible parameters as LVEF at the beginning of weaning and lactates variation (%) in the first 12-24 h from weaning begin were the most accurate predictors of death after weaning.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Single Center Experience in the Management of Cardiogenic Shock Using Temporary Mechanical Circulatory Support Devices - Impella CP, Impella 5.0, IABP, and ECMO
    Goulet, C.
    Joyce, D.
    Mohammed, A.
    Joyce, L.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2019, 38 (04): : S437 - S437
  • [32] A Contemporary Report Of Clinical Outcomes Associated With Impella 5.5 In Patients With Cardiogenic Shock
    Riaz, Sana
    Konstantinidis, Ippokratis
    Tysarowski, Maciej
    Gluck, Jason
    Ayyazali
    Jaiswal, Abhishek
    JOURNAL OF CARDIAC FAILURE, 2024, 30 (01) : 237 - 237
  • [33] CLINICAL OUTCOMES AMONG IMPELLA 5.0/5.5 RECIPIENTS WITH CARDIOGENIC SHOCK: A REPORT FROM THE CARDIOGENIC SHOCK WORKING GROUP
    Fried, Justin
    Farr, MaryJane A.
    Kanwar, Manreet
    Garan, Arthur R.
    Hernandez-Montfort, Jaime
    Sinha, Shashank S.
    Sangal, Paavni
    Kong, Qiuyue
    Li, Borui
    Uriel, Nir
    Burkhoff, Daniel
    Kapur, Navin
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 342 - 342
  • [34] Clinical Outcomes of Endoscopic Endonasal Odontoidectomy: A Single-Center Experience
    Grose, Elysia
    Moldovan, Ioana D.
    Kilty, Shaun
    Agbi, Charles
    Lamothe, Andre
    Alkherayf, Fahad
    WORLD NEUROSURGERY, 2020, 137 : E406 - E415
  • [35] Clinical Outcomes of Re-transplantation: A Single-center Experience
    Kwon, J. H.
    Song, G. -W.
    Kim, W. -J.
    Chung, Y.
    Ha, S. -M.
    Hwang, S.
    Kim, K. -H.
    Ahn, C. -S.
    Moon, D. -B.
    Ha, T. -Y.
    Jung, D. -H.
    Park, G. -C.
    Lee, S. -G.
    TRANSPLANTATION, 2017, 101 (05) : 230 - 230
  • [36] Post-Impella® Implant Mortality Determinants and Associated Lactate Levels in Cardiogenic Shock Patients - A Single Center Experience
    Ji, Yong
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (13) : B197 - B197
  • [37] Mixed Shock Complicating Cardiogenic Shock: Frequency, Predictors, and Clinical Outcomes
    Baldetti, Luca
    Gallone, Guglielmo
    Filiberti, Gaia
    Pescarmona, Luca
    Cesari, Andrea
    Rizza, Vincenzo
    Roagna, Edoardo
    Gurrieri, Davide
    Peveri, Beatrice
    Nocera, Lorenzo
    Cianfanelli, Lorenzo
    Marcelli, Gianluca
    De Lio, Giulia
    Boretto, Paolo
    Angelini, Filippo
    Gramegna, Mario
    Pazzanese, Vittorio
    Sacchi, Stefania
    Calvo, Francesco
    Ajello, Silvia
    De Ferrari, Gaetano Maria
    Frea, Simone
    Scandroglio, Anna Mara
    CIRCULATION-HEART FAILURE, 2024, 17 (07)
  • [38] Clinical Outcomes Among Impella 5.0/5.5 Recipients with Cardiogenic Shock: A Report from The Cardiogenic Shock Working Group
    Farr, M.
    Fried, J.
    Montfort, J. Hernandez
    Sinha, S.
    Kanwar, M.
    Garan, A.
    Uriel, N.
    Li, B.
    Kong, Q.
    Sangal, P.
    Burkoff, D.
    Kapur, N.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2024, 43 (04): : S27 - S28
  • [39] Upfront Impella 5.0 vs. Prior Mechanical Circulatory Support Use in Cardiogenic Shock: A Single Center Experience
    Bashline, M. J.
    Kola, O.
    Kilic, A.
    Sciortino, C.
    Toma, C.
    Mulukutla, S.
    Fowler, J.
    Hickey, G.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2021, 40 (04): : S431 - S432
  • [40] OUTCOMES WITH IMPELLA IN NON-AMI CARDIOGENIC SHOCK
    Amancherla, Kaushik
    Patel, Jay
    Haddad, Elias V.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 930 - 930